• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
22.92
15943.23
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.48
 

cinevista ltd
Fermenta Biotech receives FSSAI approval for its Vitamin D3 (Cholecalciferol) - Plant Source
Jul 06,2026

Fermenta Biotech announced that its Vitamin D3 (Cholecalciferol) - Plant Source (VITADEE Green®) has received approval from the Food Safety and Standards Authority of India (FSSAI) for use as an ingredient in Health Supplements, Nutraceuticals and Food Products.

The approval allows Indian food and supplement manufacturers to use VITADEE Green® in fortified staple foods, food and beverages, dietary supplements and nutraceuticals, addressing one of the most pressing gaps in the country's nutritional landscape.

Studies estimate that a large percentage of the Indian population has suboptimal Vitamin D levels, a deficiency increasingly linked to urbanisation, indoor lifestyles and limited sun exposure despite the country's geography.